Roche bid to retool arthritis drug for COVID-19 fails
ZURICH : Roche’s attempt to retool its rheumatoid arthritis drug Actemra/RoActemra to treat patients hospitalised with severe COVID-19-related pneumonia has failed in a late-stage trial, the Swiss company said on…